KNSA - Kiniksa Pharmaceuticals files for $400M mixed shelf
2024-06-28 18:21:11 ET
More on Kiniksa Pharmaceuticals
- Kiniksa Pharmaceuticals: Arcalyst Performs While Abiprubart Plans Take Shape
- Kiniksa Pharmaceuticals Q1 2024 Earnings Call Transcript
- Kiniksa Pharmaceuticals 2024 Q1 - Results - Earnings Call Presentation
- Seeking Alpha’s Quant Rating on Kiniksa Pharmaceuticals
- Historical earnings data for Kiniksa Pharmaceuticals